| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
27-OH-BCI-210
1
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description: structure in first source
Bio-Agent Context: Research Results
Related Diseases
| 1. | Neoplasms (Cancer)
11/01/2005
- "We compared the ability of 27-OH-BCI-210 with calcitriol to inhibit proliferation of prostate (LNCaP), and breast (MCF-7) cancer cells"
Get all the results and reference details, order at left... |
| 2. | Breast Neoplasms (Breast Cancer)
11/01/2005
- "These synergistic interactions suggest the potential clinical utility of 27-OH-BCI-210 in the treatment of prostate and breast tumors."
Get all the results and reference details, order at left... |
| 2 Diseases and 1 more articles analyzed in the Research Interface, order at left... | |
Related Drugs and Biologics
| 1. | Calcitriol (Calcijex)
|
| 1 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left... | |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License details >>
| Price: | $490.00 access via web interface, 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |